澳大利亚和新西兰烧伤患者的血流感染与多重耐药菌获得:一项基于登记的研究
该研究分析澳大利亚和新西兰烧伤登记处(BRANZ)2016年7月至2021年6月的数据,考察多重耐药菌(MDRO)与血流感染(BSI)的关联。目标耐药菌低发生率(3.4%),研究期间无变化,频率随年龄和烧伤面积增加;BSI阳性率1.6%(占送检培养的12.1%),中位伤后10.2天。
要点
- 目标耐药菌总发生率为3.4%,研究期间无变化,频率随年龄和烧伤面积增加。
- BSI阳性率1.6%(占送检培养的12.1%),中位伤后10.2天出现。
- MRSA在所有年龄组中最常见;建议采用标准化实验室报告框架以支持感染预防。
核心结论
- 目标MDRO和BSI的低发生率及获得模式与大面积烧伤低发生率国家的报告相当。
- 更广泛采用标准化实验室报告框架有助于临床质量登记处提供支持循证感染预防举措的数据。
研究设计与样本
- 基于澳大利亚和新西兰烧伤登记处(BRANZ)的登记研究,分析2016年7月至2021年6月的数据。
- 评估目标MDRO(MRSA、VRE、CRP、CRE)与BSI的患病率、危险因素和结局,并评价数据完整性和质量改进价值。
主要发现
- 目标耐药菌发生率为3.4%,研究期间无变化,频率因服务机构而异,并随年龄和烧伤面积增加。
- MRSA在所有年龄组中最常见。
- BSI阳性见于1.6%的患者(占送检培养的12.1%),中位时间为伤后10.2天。
- 病原体自由文本记录不一致。
临床怎么用
- 作者认为更广泛采用标准化实验室报告框架有助于临床质量登记处提供支持循证感染预防举措的数据。
局限性
- 病原体自由文本记录不一致。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study interrogates infection related data in the Burns Registry of Australia and New Zealand (BRANZ), to examine associations of multi-drug resistant organisms (MDROs) and blood stream infection (BSI). METHODS: Data between July 2016 and June 2021 were analysed to determine prevalence, risk factors and outcomes associated with BSIs and MDROs: Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), carbapenem-resistant Pseudomonas spp. (CRP), and carbapenem-resistant Enterobacter (CRE). Data completeness and value for quality improvement activity were assessed. RESULTS: We found a low incidence (3.4%) of the resistant organisms of interest, and no change over the study period. Fequency varied between services and increased with age and size of burn. MRSA was the commonest organism in all age groups. A positive BSI result occurred in 1.6% of patients (12.1% of cultures taken) at a median time of 10.2 days post injury. Free text identification of organisms was inconsistently documented. CONCLUSIONS: The low rate and patterns of acquisition of MDROs of interest and BSIs is comparable with reports from countries with low incidence of massive burns. Wider adoption of a standardized laboratory reporting framework would help realise the potential of clinical quality registries to provide data which supports evidence based infection prevention initiatives.
引用
- Cleland H, Stewardson A, Padiglione A, et al. Bloodstream infections and multidrug resistant bacteria acquisition among burns patients in Australia and New Zealand: A registry-based study. Burns. 2024. PMID: 38714428. doi:10.1016/j.burns.2024.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。